Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study
Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2024
|
| オンライン･アクセス: | https://doi.org/10.3390/children11020170 https://www.mdpi.com/2227-9067/11/2/170/pdf?version=1706432217 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|